Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSThe application of data science to human data is already happening in healthcare and its impact is positive.
Let’s look at the impact of Human Data Science on three levels:
The first is at the health system level.
The second is at a disease prevention and treatment level,
And the third level focuses on delivering human health services.
At the health system level, unnecessary services can drive up costs and expose patients to stress and risks.
Many ACOs function under global payment models that were created to meet the needs of high-risk patients.
But are they really effective?
If we only look at high-risk patients, we are missing the boat on achieving the most effective use of health system resources.
Many strategies are incentivized by global payment models that focus only on reducing waste and lowering spending in high-risk patients. But what if we want to know the best way to reduce waste and spending overall?
An analysis of Part A and B Medicare claims shows that 17% of Medicare beneficiaries were considered at high-risk of incurring future costs.
However, those patients only accounted for 27% of low-value service use.
So, targeting patients with high predicted spending misses opportunities for waste reduction.
The application of Human Data Science to look at overall patient wellness actually reduced unnecessary, low-value tests and treatments for all patients.
Now let’s look at Human Data Science in the context of disease prevention, interception, and treatment.
Patient engagement and the collection and use of anonymized patient data used with advanced analytics can bring life-altering therapies to humans in ways we didn’t think were feasible.
Let’s explore two current cancer therapies: Roche’s Rozlytrek and Pfizer’s Imbrance.
In both cases, the drug development approval pipeline needed patient subgroups that are very challenging to recruit for in a traditional clinical trial.
Instead of going a traditional route that would delay the delivery of life-altering treatments, a different approach, an approach drive by Human Data Science was needed.
In both cases the companies developed clinical programs driven by real world data and evidence to identify patients for clinical trials.
The use of Real World evidence was multidimensional—used as a comparator and as a virtual control arm in the clinical trials.
Furthermore, this human data science approach using real world evidence, positively impacted the regulatory filing and approval process.
In our last example, we look at healthcare delivery as it relates to maternal care.
Gaps in longitudinal patient care, and particularly maternal care where there is a general lack of robust data collection, are missed opportunities to support patients and mitigate health risk.
The United States currently lacks uniform care in the postpartum period, when more than 60% of global maternal deaths occur.
There is a need for national data collection on postpartum maternal morbidity to address gaps in this care.
By examining human health through a human data science lens, The Arkansas Health Care Payment Improvement Initiative showed that a bundled payment model actually led to a decrease in episode spending while simultaneously improving the maternal care services.
This type of program incentivizes better care coordination and quality.
Beyond the real-time impact on care for the mother, the data collected from these programs can be analyzed to determine if quality goals are being met and their impact on cost----ultimately to continually improve care and inform future decisions.
We can see where challenges and gaps in healthcare worldwide are daunting.
But a change in approach can make a difference in outcome. This new approach known as Human Data Science is happening and offers reason to be optimistic.
The powerful forces of human ingenuity, breakthrough science, and disruptive technology that Human Data Science has unleashed promise to power future healthcare advances and improve health outcomes for individuals and populations globally.
Explore Human Data Science in this video series that breaks out the Current State of Healthcare, The Principles of Human Data Science, The Stakeholder Impact of Human Data Science, and Human Data Science in Action.
To solve the biggest challenges in human health, and realize the potential of big data in healthcare, we need more than data science. We need Human Data Science.
A New Approach to Improving Human Health Outcomes
